Eli Lilly files quarterly report (10-Q) for the period ended Mar 31, 2026
Eli Lilly filed its quarterly report on Form 10-Q with the SEC on Apr 30, 2026, 11:25 AM ET, covering the quarter ended Mar 31, 2026. It reports fiscal Q1 2026 results.
- Revenue: $19.80B (+55.5% from $12.73B a year earlier)
- Net income: $7.40B (+168.1% from $2.76B a year earlier)
- Diluted EPS: $8.26 (+169.9% from $3.06 a year earlier)
- Form 10-Q accepted by EDGAR Apr 30, 2026, 11:25 AM ET
- Accession number 0000059478-26-000045
LLY around the story · hourly24 h reaction ▲ 3.34%
Source
SEC EDGARApr 30, 2026, 11:25 AM ET
SEC filing 10-Q · accession 0000059478-26-000045 · sec.gov ↗